The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients

Sponsor

Hillel Yaffe Medical Center (Other)

Overall Status

Unknown status

CT.gov ID

NCT00987012

Collaborator

Gan shmuel Group (Other)

200

Enrollment

Location

Arms

Study Details

Study Description

Brief Summary

It has been shown in laboratory studies that pomegranate juice contains anti-viral action against influenza. The researchers wish to investigate the effect of pomegranate juice on patients suffering from influenza A (seasonal or swine flu).

Condition or Disease	Intervention/Treatment	Phase
Influenza A Swine Flu	Dietary Supplement: Pomegranate juice Dietary Supplement: Placebo drink	N/A

Study Design

Study Type:

Interventional

Anticipated Enrollment :

200 participants

Allocation:

Randomized

Intervention Model:

Parallel Assignment

Masking:

Double (Participant, Investigator)

Primary Purpose:

Treatment

Official Title:

The Influence of Fortified Pomegranate Juice (Punica Granatum) on Seasonal Influenza and Swine Flu Patients - A Prospective Randomized Trial

Study Start Date :

Oct 1, 2009

Anticipated Primary Completion Date :

Apr 1, 2010

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Pomegranate juice	Dietary Supplement: Pomegranate juice Twice daily ingestion of pomegranate juice over 4-5 days
Placebo Comparator: Placebo drink	Dietary Supplement: Placebo drink Twice daily ingestion of placebo drink over 4-5 days

Arm

Intervention/Treatment

Experimental: Pomegranate juice

Dietary Supplement: Pomegranate juice

Twice daily ingestion of pomegranate juice over 4-5 days

Placebo Comparator: Placebo drink

Dietary Supplement: Placebo drink

Twice daily ingestion of placebo drink over 4-5 days

Outcome Measures

Primary Outcome Measures

Early relief of influenza symptoms [Within one week]

Eligibility Criteria

Criteria

Ages Eligible for Study:

12 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Individuals confirmed and suffering from Influenza A

Exclusion Criteria:

Individuals suffering from influenza included in the high risk group

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hillel Yaffe Medical Center	Hadera		Israel	38100

Sponsors and Collaborators

Hillel Yaffe Medical Center
Gan shmuel Group

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

, ,

ClinicalTrials.gov Identifier:

NCT00987012

Other Study ID Numbers:

0044-09-HYMC

First Posted:

Sep 30, 2009

Last Update Posted:

Sep 30, 2009

Last Verified:

Sep 1, 2009

Additional relevant MeSH terms:

Influenza, Human

Study Results

No Results Posted as of Sep 30, 2009